health

Most quit breakthrough weight-loss drug within a year - ScienceDaily

A massive Danish study reveals that despite the remarkable weight-loss benefits of semaglutide, more than half of adults without diabetes stop using it within a year. High costs, unpleasant side effects, and underlying medical or psychiatric conditions play m…

Source:Science Daily
Published:
Most quit breakthrough weight-loss drug within a year - ScienceDaily
The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study bei… [+4776 chars]

Related News